beta
INBX
Inhibrx Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
development of antibodies
Market Cap: 1.69 Billion
Primary Exchange: NASDAQ
Website: https://inhibrx.com/
Shares Outstanding: 47.4 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 1.4397814209473654
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1047 trading days
From: 2020-12-17 To: 2024-03-07
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|